ALOPECIA, ANDROGENETIC
Clinical trials for ALOPECIA, ANDROGENETIC explained in plain language.
Never miss a new study
Get alerted when new ALOPECIA, ANDROGENETIC trials appear
Sign up with your email to follow new studies for ALOPECIA, ANDROGENETIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hair loss cream shows promise in large trial
Disease control CompletedThis study tested a topical solution called clascoterone against a placebo in 762 men with mild to moderate male pattern baldness. The goal was to see if it safely increases hair count and improves hair coverage over 12 months. Participants applied the solution twice daily to bal…
Matched conditions: ALOPECIA, ANDROGENETIC
Phase: PHASE3 • Sponsor: Cassiopea SpA • Aim: Disease control
Last updated May 02, 2026 08:55 UTC
-
New cream could help men regrow hair, early study shows
Disease control CompletedThis study tested a new medication called TDM-105795 for male pattern baldness. 71 men with mild to moderate hair loss used the treatment or a placebo for 16 weeks. The goal was to see if the treatment increased hair count and improved hair growth compared to no treatment.
Matched conditions: ALOPECIA, ANDROGENETIC
Phase: PHASE2 • Sponsor: Technoderma Medicines Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC